{"transactions":[{"id":731258,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $.01 per share","published_at":"2026-06-22T12:33:34.000Z","date":"2026-06-18","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":9.495,"value":75960.0,"ownership":{"direct":true},"balance_after":17785,"source":{"system":"sec-edgar","filing":"0001437749-26-021258","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774926021258/rdgdoc.xml","form_type":"4"}},{"id":831562,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (right to buy)","published_at":"2026-03-23T13:47:04.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":109500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment amends the previously reported transaction effective on 1/27/2026 to disclose the correct number of shares included in the option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year."}],"balance_after":109500,"derivative":{"exercise_price":6.265,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":109500},"source":{"system":"sec-edgar","filing":"0001437749-26-009312","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774926009312/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-29"}},{"id":928303,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-29T16:40:06.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year."}],"balance_after":110000,"derivative":{"exercise_price":6.265,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001437749-26-002366","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774926002366/rdgdoc.xml","form_type":"4"}},{"id":980761,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock $0.10 par value per share","published_at":"2025-12-04T21:11:39.000Z","date":"2025-12-04","kind":"purchase","planned":false,"acquired":true,"shares":2432,"price":5.5002,"value":13376.4864,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date."}],"balance_after":9738,"source":{"system":"sec-edgar","filing":"0001437749-25-036913","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925036913/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-03"}},{"id":980760,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock $0.10 par value per share","published_at":"2025-12-04T21:11:39.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":3598,"price":5.045,"value":18151.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased."}],"balance_after":7306,"source":{"system":"sec-edgar","filing":"0001437749-25-036913","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925036913/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-03"}},{"id":982761,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock $0.10 par value per share","published_at":"2025-12-03T21:14:14.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":3521,"price":5.0406,"value":17747.9526,"ownership":{"direct":true},"balance_after":9785,"source":{"system":"sec-edgar","filing":"0001437749-25-036794","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925036794/rdgdoc.xml","form_type":"4"}},{"id":982760,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock $0.10 par value per share","published_at":"2025-12-03T21:14:14.000Z","date":"2025-12-03","kind":"purchase","planned":false,"acquired":true,"shares":2556,"price":5.003,"value":12787.668,"ownership":{"direct":true},"balance_after":6264,"source":{"system":"sec-edgar","filing":"0001437749-25-036794","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925036794/rdgdoc.xml","form_type":"4"}},{"id":982759,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock $0.10 par value per share","published_at":"2025-12-03T21:14:14.000Z","date":"2025-12-02","kind":"purchase","planned":false,"acquired":true,"shares":3708,"price":4.8686,"value":18052.7688,"ownership":{"direct":true},"balance_after":3708,"source":{"system":"sec-edgar","filing":"0001437749-25-036794","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925036794/rdgdoc.xml","form_type":"4"}},{"id":1003111,"issuer":{"id":6837,"kind":"organization","name":"IMMUCELL CORP /DE/"},"owners":[{"id":36565,"kind":"person","name":"te Boekhorst Paul Francis Olivier","position":1,"cik":"0002095704","reported_name":"te Boekhorst Paul Francis Olivier","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Stock Options (right to buy)","published_at":"2025-11-12T13:43:06.000Z","date":"2025-11-07","kind":"grant","planned":false,"acquired":true,"shares":74277,"price":6.1,"value":453089.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant made to Mr. te Boekhorst in connection with his commencement of employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 24,759 options on the first, second, and third anniversary of the grant date."}],"balance_after":150260,"derivative":{"exercise_price":6.1,"expiration_date":"2035-11-07","underlying":"Common Stock","underlying_shares":74277},"source":{"system":"sec-edgar","filing":"0001437749-25-034257","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811641/000143774925034257/rdgdoc.xml","form_type":"4"}}]}